6576.TWO
Price:
$77.5
Market Cap:
$12.21B
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
Industry
Medical - Pharmaceuticals
IPO Date
2016-04-12
Stock Exchange
TWO
Ticker
6576.TWO
According to Foresee Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 1.93%. This represents a change of -209.66% compared to the average of -1.76% of the last 4 quarters.
The mean historical ROE of Foresee Pharmaceuticals Co., Ltd. over the last ten years is -52.69%. The current 1.93% ROE has changed -103.66% with respect to the historical average. Over the past ten years (40 quarters), 6576.TWO's ROE was at its highest in in the March 2026 quarter at 29.17%. The ROE was at its lowest in in the September 2024 quarter at -43.78%.
Average
-52.69%
Median
-51.91%
Minimum
-95.00%
Maximum
0%
Discovering the peaks and valleys of Foresee Pharmaceuticals Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 60.43%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -95.00%
| Year | ROE | Change |
|---|---|---|
| 2025 | -95.00% | 40.52% |
| 2024 | -67.61% | -18.81% |
| 2023 | -83.27% | 60.43% |
| 2022 | -51.91% | 20.37% |
| 2021 | -43.12% | 54.45% |
| 2020 | -27.92% | -Infinity% |
The current ROE of Foresee Pharmaceuticals Co., Ltd. (6576.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-81.96%
5-year avg
-68.18%
10-year avg
-52.69%
Foresee Pharmaceuticals Co., Ltd.’s ROE is greater than Mercury Biopharmaceutical Corporation (-24.55%), less than Handa Pharmaceuticals, Inc. (9.58%), greater than Pharmosa Biopharm Inc. (-23.20%), greater than TWi Biotechnology, Inc. (-54.05%), greater than TaiMed Biologics Inc. (-3.64%),
| Company | ROE | Market cap |
|---|---|---|
| -24.55% | $2.70B | |
| 9.58% | $22.73B | |
| -23.20% | $3.48B | |
| -54.05% | $9.85B | |
| -3.64% | $16.35B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Foresee Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Foresee Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Foresee Pharmaceuticals Co., Ltd.'s ROE?
How is the ROE calculated for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
What is the highest ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
What is the 3-year average ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
What is the 5-year average ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
How does the current ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO) compare to its historical average?